COCRYSTAL PHARMA, INC. Amortization of Debt Issuance Costs
COCRYSTAL PHARMA, INC. (COCP) reported Amortization of Debt Issuance Costs of $404 for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2014-03-31
- COCRYSTAL PHARMA, INC. amortization of debt issuance costs for the quarter ending 2013-09-30 was -$3.42K, a 119.09% decline year-over-year.
- COCRYSTAL PHARMA, INC. amortization of debt issuance costs for the quarter ending 2013-06-30 was $1.91K, a 0.05% decline year-over-year.
- COCRYSTAL PHARMA, INC. amortization of debt issuance costs for the quarter ending 2013-03-31 was $1.91K, a 0.05% increase year-over-year.
- COCRYSTAL PHARMA, INC. amortization of debt issuance costs for the quarter ending 2012-12-31 was $14.58K.
- COCRYSTAL PHARMA, INC. amortization of debt issuance costs for fiscal 2012 was $36.30K, a 77.37% decline from fiscal 2011.
- COCRYSTAL PHARMA, INC. amortization of debt issuance costs for fiscal 2011 was $160.41K, a 2067.38% increase from fiscal 2010.
- COCRYSTAL PHARMA, INC. amortization of debt issuance costs for fiscal 2010 was $7.40K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month | Amortization of Debt Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2013-09-30 | -$3.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-18 | -$1.51K derived: sum of 2 quarters · filed 2013-11-18 | $404.00 10-Q · filed 2013-11-18 | $14.98K derived: sum of 4 quarters · filed 2014-03-31 | |
| 2013-06-30 | $1.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-15 | $3.82K 10-Q · filed 2013-08-15 | $18.40K derived: sum of 3 quarters · filed 2014-03-31 | $36.30K derived: sum of 4 quarters · filed 2014-03-31 | |
| 2013-03-31 | $1.91K 10-Q · filed 2013-05-10 | $16.49K derived: sum of 2 quarters · filed 2014-03-31 | $34.39K derived: sum of 3 quarters · filed 2014-03-31 | $36.30K derived: sum of 4 quarters · filed 2014-03-31 | |
| 2012-12-31 | $14.58K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $32.48K derived: sum of 2 quarters · filed 2014-03-31 | $34.39K derived: sum of 3 quarters · filed 2014-03-31 | $36.30K 10-K · filed 2014-03-31 | $43.95K 10-K · filed 2013-04-01 |
| 2012-09-30 | $17.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-18 | $19.81K derived: sum of 2 quarters · filed 2013-11-18 | $21.72K 10-Q · filed 2013-11-18 | ||
| 2012-06-30 | $1.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-15 | $3.82K 10-Q · filed 2013-08-15 | |||
| 2012-03-31 | $1.91K 10-Q · filed 2013-05-10 | ||||
| 2011-12-31 | $160.41K 10-K · filed 2013-04-01 | ||||
| 2011-03-31 | $6.75K 10-Q/A · filed 2012-10-02 | ||||
| 2010-12-31 | $7.40K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |